Palo Alto Investors’s NxStage Medical Inc. NXTM Stock Holding History

Palo Alto Investors’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-20,200	Closed	-$362K	–	48
2014 Q4	$362K	Buy	+20,200	New	+$325K	0.02%	44
2013 Q4	–	Sell	-44,129	Closed	-$581K	–	35
2013 Q3	$581K	Hold	44,129	–	–	0.06%	31
2013 Q2	$630K	Buy	+44,129	New	+$555K	0.07%	32

Other funds holding NXTM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

CIP

Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Palo Alto Investors's NXTM Position: Q1 2015 in Review

Palo Alto Investors sold out of NxStage Medical Inc. (NXTM) in Q1 2015, closing a stake of 20,200 shares — an estimated $362K sold.

Palo Alto Investors first reported a position in NXTM in Q2 2013 and held it in 3 quarters. The position peaked at $630K in Q2 2013. 122 funds tracked by Wall St. Rank hold NXTM as of Q1 2015.

Palo Alto Investors reported no remaining NxStage Medical Inc. position as of Q1 2015 after selling out during the quarter.
Palo Alto Investors sold 20,200 NxStage Medical Inc. shares in Q1 2015, an estimated $362K.
Palo Alto Investors first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 3 quarters.
Palo Alto Investors's NxStage Medical Inc. position peaked at $630K in Q2 2013.
122 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2015.

Based on Palo Alto Investors's 13F filing for Q1 2015, filed 15 May 2015.